Pub Date : 2020-03-15DOI: 10.5639/gabij.2020.0901.007
E. Bird
{"title":"Top developments in biosimilars during 2019","authors":"E. Bird","doi":"10.5639/gabij.2020.0901.007","DOIUrl":"https://doi.org/10.5639/gabij.2020.0901.007","url":null,"abstract":"","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"23 1","pages":"37-44"},"PeriodicalIF":0.0,"publicationDate":"2020-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86339592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-03-15DOI: 10.5639/gabij.2020.0901.005
M. F. Jorge
While Americans are deeply concerned about drug prices, the United States Trade Representative (USTR) continues to negotiate agreements like the United States-Mexico-Canada Agreement (USMCA) that put at risk the sustainability of the generics industry and undermine the development of biosimilars that play a critical role in access to medicines. It is time to restore some balance to US trade policy.
{"title":"It is time to change US trade policy to foster access to medicines","authors":"M. F. Jorge","doi":"10.5639/gabij.2020.0901.005","DOIUrl":"https://doi.org/10.5639/gabij.2020.0901.005","url":null,"abstract":"While Americans are deeply concerned about drug prices, the United States Trade Representative (USTR) continues to negotiate agreements like the United States-Mexico-Canada Agreement (USMCA) that put at risk the sustainability of the generics industry and undermine the development of biosimilars that play a critical role in access to medicines. It is time to restore some balance to US trade policy.","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"11 1","pages":"25-27"},"PeriodicalIF":0.0,"publicationDate":"2020-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85161814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-25DOI: 10.5639/GABIJ.2019.0803.012
B. Godman, E. Allocati, Evelien Moorkens
Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.
Siu等人全面评估了加拿大生物制剂和生物仿制药快速变化的监管和报销环境及其产生的影响。
{"title":"Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective","authors":"B. Godman, E. Allocati, Evelien Moorkens","doi":"10.5639/GABIJ.2019.0803.012","DOIUrl":"https://doi.org/10.5639/GABIJ.2019.0803.012","url":null,"abstract":"Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90156415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-15DOI: 10.5639/gabij.2019.0803.017
Z. Maravic
{"title":"Why ‘similar’ can make a big difference","authors":"Z. Maravic","doi":"10.5639/gabij.2019.0803.017","DOIUrl":"https://doi.org/10.5639/gabij.2019.0803.017","url":null,"abstract":"","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"58 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74208497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-15DOI: 10.5639/gabij.2019.0803.013
S. Kozlowski, E. Tworkoski, Carmen Dekmezian, Yanchang Zhang, Natasha Flowers, Alvin So, Andreas Schick, M. Wernecke, T. MaCurdy, J. Kelman
{"title":"Pharmacy chain drives choice among manufacturers of generic drugs in the US Medicare population","authors":"S. Kozlowski, E. Tworkoski, Carmen Dekmezian, Yanchang Zhang, Natasha Flowers, Alvin So, Andreas Schick, M. Wernecke, T. MaCurdy, J. Kelman","doi":"10.5639/gabij.2019.0803.013","DOIUrl":"https://doi.org/10.5639/gabij.2019.0803.013","url":null,"abstract":"","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73883360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-15DOI: 10.5639/gabij.2019.0803.014
E. Siu, A. Tomalin, K. West, S. Anderson, G. Wyatt
{"title":"An ever-evolving landscape: an update on the rapidly changing regulation and reimbursement of biosimilars in Canada","authors":"E. Siu, A. Tomalin, K. West, S. Anderson, G. Wyatt","doi":"10.5639/gabij.2019.0803.014","DOIUrl":"https://doi.org/10.5639/gabij.2019.0803.014","url":null,"abstract":"","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80051327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-15DOI: 10.5639/gabij.2019.0803.016
J. D. Vlieger, D. Crommelin, B. Flühmann, I. Klebovich, S. Mühlebach, V. Shah
{"title":"A progress report on the 3rd International Symposium on Scientific and Regulatory Advances in Biological and Non-Biological Complex Drugs: A to Z in Bioequivalence","authors":"J. D. Vlieger, D. Crommelin, B. Flühmann, I. Klebovich, S. Mühlebach, V. Shah","doi":"10.5639/gabij.2019.0803.016","DOIUrl":"https://doi.org/10.5639/gabij.2019.0803.016","url":null,"abstract":"","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87487610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-15DOI: 10.5639/gabij.2019.0802.010
GaBI Journal Editor
{"title":"Escalating prices of generic drugs targeted by US anti-gouging legislation","authors":"GaBI Journal Editor","doi":"10.5639/gabij.2019.0802.010","DOIUrl":"https://doi.org/10.5639/gabij.2019.0802.010","url":null,"abstract":"","PeriodicalId":43994,"journal":{"name":"GaBI Journal-Generics and Biosimilars Initiative Journal","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87044881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：